Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Nimotuzumab Plus PF as Induction Chemotherapy in Patients With Locally Advanced HNSCC

NCT00910117 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00910117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Nimotuzumab Plus PF as Induction Chemotherapy in Patients With Locally Advanced HNSCC
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2009
Completion date
December 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer